Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Chen, Jia ^a   Li, Zhong Yuan ^a,b   Huang, Si Yang ^a   Petersen, Eskild ^c   Song, Hui Qun ^a   Zhou, Dong Hui ^a   Zhu, Xing Quan ^a,b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

DNA vaccine; Protective immunity; pVAX IL 15 IL 21; TgCDPK1; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

CALCIUM DEPENDENT PROTEIN KINASE 1; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG; CALCIUM PROTEIN KINASE; CALCIUM-DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN G; INTERLEUKIN DERIVATIVE; PROTEIN KINASE; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; PROTOZOON ANTIBODY;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; KUNMING MOUSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RECOMBINANT PLASMID; SPLEEN CELL; SURVIVAL TIME; TH1 CELL; TOXOPLASMOSIS; ANIMAL; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; PARASITOLOGY; TOXOPLASMA;

ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERLEUKIN-15; INTERLEUKINS; MICE; PROTEIN KINASES; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, DNA;

EID: 84907024463     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-487     Document Type: Article

References (36)

1. Chen J, Xu MJ, Zhou DH, Song HQ, Wang CR, Zhu XQ. Canine and feline parasitic zoonoses in China. Parasit Vectors 2012, 5:152. 10.1186/1756-3305-5-152, 3431282, 22839365.
2. Duan G, Tian YM, Li BF, Yang JF, Liu ZL, Yuan FZ, Zhu XQ, Zou FC. Seroprevalence of Toxoplasma gondii infection in pet dogs in Kunming, Southwest China. Parasit Vectors 2012, 5:118. 10.1186/1756-3305-5-118, 3407528, 22704457.
3. Miao Q, Wang X, She LN, Fan YT, Yuan FZ, Yang JF, Zhu XQ, Zou FC. Seroprevalence of Toxoplasma gondii in horses and donkeys in Yunnan Province, Southwestern China. Parasit Vectors 2013, 6:168. 10.1186/1756-3305-6-168, 3679964, 23742078.
4. Robert-Gangneux F, Darde´ ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012, 25:264-296. 10.1128/CMR.05013-11, 3346298, 22491772.
5. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsayand DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 2010, 26:190-196. 10.1016/j.pt.2010.01.009, 20202907.
6. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol 2009, 39:895-901. 10.1016/j.ijpara.2009.02.004, 2704023, 19217908.
7. Dubey JP. Toxoplasmosis in sheep-the last 20 years. Vet Parasitol 2009, 163:1-14. 10.1016/j.vetpar.2009.02.026, 19395175.
8. Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012, 139:1375-1424. 10.1017/S0031182012000765, 22776427.
9. Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol 2008, 38:1359-1370. 10.1016/j.ijpara.2008.06.002, 18694755.
10. Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccine 2013, 12:1287-1299.
11. Innes EA. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?. Expert Rev Vaccines 2010, 9:1117-1119. 10.1586/erv.10.113, 20923261.
12. Gurunathan S, Klinman D, Seder RA. DNA vaccines: immunology, application and optimization. Annu Rev Immunol 2000, 18:927-974. 10.1146/annurev.immunol.18.1.927, 10837079.
13. Hoft DF, Eickhoff CS, Giddings OK, Vasconcelos JR, Rodrigues MM. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J Immunol 2007, 179:6889-6900. 10.4049/jimmunol.179.10.6889, 17982080.
14. Cherif MS, Shuaibu MN, Kurosaki T, Helegbe GK, Kikuchi M, Yanagi T, Tsuboi T, Sasaki H, Hirayama K. Immudnogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Vaccine 2011, 29:9038-9050. 10.1016/j.vaccine.2011.09.031, 21939717.
15. McCoy JM, Whitehead L, van Dooren GG, Tonkin CJ. TgCDPK3 regulates calcium-dependent egress of Toxoplasma gondii from host cells. PLoS Pathog 2012, 8:1003066.
16. Billker O, Lourido S, Sibley LD. Calcium-dependent signaling and kinases in apicomlexan parasites. Cell Host Microbe 2009, 5:612-622. 10.1016/j.chom.2009.05.017, 2718762, 19527888.
17. Lourido S, Shuman J, Zhang C, Shokat KM, Hui R, Sibley LD. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma. Nature 2010, 465:359-362. 10.1038/nature09022, 2874977, 20485436.
18. Cui FD, Asada H, Jin ML, Kishida T, Shin-Ya M, Nakaya T, Kita M, Ishii M, Iwai M, Okanoue T, Imanishi J, Mazda O. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Gene Ther 2005, 12:160-168. 10.1038/sj.gt.3302393, 15470476.
19. Bolesta E, Kowalczyk A, Wierzbicki A, Eppolito C, Kaneko Y, Takiguchi M, Stamatatos L, Shrikant PA, Kozbor D. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J Immunol 2006, 177:177-191. 10.4049/jimmunol.177.1.177, 2504862, 16785513.
20. Hryniewicz A, Price DA, Moniuszko M, Boasso A, Edghill-Spano Y, West SM, Venzon D, Vaccari M, Tsai WP, Tryniszewska E, Nacsa J, Villinger F, Ansari AA, Trindade CJ, Morre M, Brooks D, Arlen P, Brown HJ, Kitchen CM, Zack JA, Douek DC, Shearer GM, Lewis MG, Koup RA, Franchini G. Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol 2007, 178:3492-3504. 10.4049/jimmunol.178.6.3492, 17339444.
21. Li ZY, Chen J, Petersen E, Zhou DH, Huang SY, Song HQ, Zhu XQ. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014, 32:3058-3065. 10.1016/j.vaccine.2014.03.042, 24690150.
22. Bounous DI, Campagnoli RP, Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 1992, 36:1022-1027. 10.2307/1591566, 1485851.
23. Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, Zhang NZ, Zhu XQ. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine 2013, 31:1734-1739. 10.1016/j.vaccine.2013.01.027, 23370151.
24. Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, Zhou Y, Yang GL, Zhu XQ. Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine 2013, 31:3135-3139. 10.1016/j.vaccine.2013.05.040, 23707448.
25. Min J, Qu D, Li C, Song X, Zhao Q, Li XA, Yang Y, Liu Q, He S, Zhou H. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplamosis in mice using a prime-boost vaccination strategy. Vaccine 2012, 30:5631-5636. 10.1016/j.vaccine.2012.06.081, 22789504.
26. Cui X, Lei T, Yang D, Hao P, Li B, Liu Q. Toxoplasma gondii immune mapped protein-1(TgIMP1) is a novel vaccine candidate against toxoplasmosis. Vaccine 2012, 30:2282-2287. 10.1016/j.vaccine.2012.01.073, 22310204.
27. Denkers EY, Bzik DJ, Fox BA, Butcher BA. An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii. Infect Immun 2012, 80:476-482. 10.1128/IAI.05974-11, 3264314, 22104110.
28. Grover HS, Blanchard N, Gonzalez F, Chan S, Robey EA, Shastri N. The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden. Infect Immun 2012, 80:3279-3288. 10.1128/IAI.00425-12, 3418726, 22778097.
29. Correa D, Cañedo-Solares I, Ortiz-Alegri´a LB, Caballero-Ortega H, Rico-Torres CP. Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol 2007, 29:651-660. 10.1111/j.1365-3024.2007.00982.x, 18042171.
30. Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 2012, 34:793-813. 10.1007/s00281-012-0339-3, 3498595, 22955326.
31. Zhang NZ, Huang SY, Zhou DH, Chen J, Xu Y, Tian WP, Lu J, Zhu XQ. Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3. BMC Infect Dis 2013, 13:512. 10.1186/1471-2334-13-512, 24176018.
32. Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol Rev 2011, 240:269-285. 10.1111/j.1600-065X.2010.00992.x, 21349099.
33. Donnelly JJ, Wahren B, Liu MA. DNA vaccines: progress and challenges. J Immunol 2005, 175:633-639. 10.4049/jimmunol.175.2.633, 16002657.
34. Yan HK, Yuan ZG, Petersen E, Zhang XX, Zhou DH, Liu Q, He Y, Lin RQ, Xu MJ, Chen XL, Zhong XL, Zhu XQ. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol 2011, 128:38-43. 10.1016/j.exppara.2011.02.005, 21310148.
35. Wang PY, Yuan ZG, Petersen E, Li J, Zhang XX, Li XZ, Li HX, Lv ZC, Cheng T, Ren D, Yang GL, Lin RQ, Zhu XQ. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol 2012, 19:1916-1920. 10.1128/CVI.00397-12, 3535859, 23015648.
36. Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, Hoft DF. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. PLoS Negl Trop Dis 2011, 5:e983. 10.1371/journal.pntd.0000983, 3050911, 21408124.